Safety and efficacy of Chitra-CPC calcium phosphate cement as bone substitute

Simple item page
dc.contributor.authorFernandez, AC
dc.contributor.authorMohanty, M
dc.contributor.authorVarma, HK
dc.contributor.authorKomath, M
dc.date.accessioned2017-03-10T03:28:30Z
dc.date.available2017-03-10T03:28:30Z
dc.date.issued2006
dc.description.abstractCalcium phosphate cements (CPCs) have gained importance in orthopaedics and dentistry as repair materials for bony/dentinal defects. They are aqueous based, mouldable and osteoconductive materials which set into hydroxyapatite, the basic mineral of bone and teeth. A CPC product 'Chitra-CPC' has been developed. This communication compiles the safety and efficacy evaluation of Chitra-CPC. The evaluation plan consisted of acute systemic toxicity test (in mice for systemic response), intracutaneous reactivity test (in rabbits for skin response), pyrogen test (in rabbits for presence of pyrogens) and maximization sensitization test (in guinea pigs for allergic skin response). Soft tissue response was tested by implantation in rabbit paravertebral muscle, with histological evaluation at 1, 4 and 12 weeks post-implantation. The efficacy of the product to heal bone defects was investigated by implanting in rabbit femur with hydroxyapatite ceramic granules as the control. Local effects at macroscopic and microscopic levels were assessed at time periods of 4, 12, 26 and 52 weeks post implantation. The cement did not show any adverse effects in the acute systemic toxicity. Nor did it elicit any erythemic or edematous reactivity in the intracutaneous reactivity test. The maxindzation sensitization study did not show any adverse skin response and the pyrogen test did not evoke undue temperature rise. In the muscle implantaion test, there was no haemorrhage, infection or necrosis. Localized vascularization was present near the implanted region. Chronic inflammation was observed in 1 week, which became mild by 12 weeks with the evidence of repair. Bone implantation studies showed that efficacy of Chitra-CPC and hydroxyapatite granules in bone healing is comparable. Both materials were found to be osteoconductive, but with the difference that Chitra-CPC resorbed progressively allowing simultaneous new bone formation. This proves the osteotransductivity of Chitra-CPC, which is the ideal property for a bone substitute.
dc.identifier.citation91 ,12;1678-1686en_US
dc.identifier.urihttps://dspace.sctimst.ac.in/handle/123456789/10405
dc.publisherCURRENT SCIENCE
dc.subjectScience & Technology - Other Topics
dc.titleSafety and efficacy of Chitra-CPC calcium phosphate cement as bone substitute
Files
Collections
Journal Articles